Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / DMT:CC - Small Pharma: Stocks Undervalued by Analyst Consensus on TSX-V (DMT)


DMT:CC - Small Pharma: Stocks Undervalued by Analyst Consensus on TSX-V (DMT)

2023-08-31 20:00:00 ET

Small Pharma Inc is among the group of undervalued stocks on the TSX Venture Exchange. This means the consensus value for each stock on this list is above its current price.

This report is generated monthly. It provides the close price and target price for these companies along with the number of analysts covering the stock. Also included is the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year. Stocks in this category are held primarily for capital appreciation.

There may be a number of reasons why a company would be on this list. Companies with a large analyst following with a difference in price versus target are worth exploring in more detail.

Symbol Name Target Year Close Price Target Price Mean Currency Target Price # Estimates
SGML
Sigma Lithium Corp
2023
49.38
70.1
CAD
5
PMET
Patriot Battery Metals Inc
2024
13.74
18.25
CAD
5
ARTG
Artemis Gold Inc
2023
5.31
11.4688
CAD
8
NFG
New Found Gold Corp
2023
6.18
10.4333
CAD
3
SLI
Standard Lithium Corp
2024
5.94
11
CAD
2
LI
American Lithium Corp
2024
2.58
7.5
CAD
1
ISO
IsoEnergy Ltd
2023
2.62
6.4375
CAD
4
ODV
Osisko Development Corp
2023
5.57
9.77
CAD
5
LTH
Lithium Ionic Corp
2023
2.34
5.625
CAD
2
MTA
Metalla Royalty & Streaming Ltd
2023
6.14
10
CAD
3
ETL
E3 Lithium Ltd
2023
2.56
10
CAD
1
NOU
Nouveau Monde Graphite Inc
2023
3.95
8.5
CAD
1
GIP
Green Impact Partners Inc
2023
8
16.75
CAD
4
HITI
High Tide Inc
2024
1.65
5.875
CAD
4
EMO
Emerita Resources Corp
2024
0.395
3.75
CAD
1
ITR
Integra Resources Corp
2023
1.2
4.5167
CAD
6
KUT
Redishred Capital Corp
2023
3.69
7.3333
CAD
3
PVT
Pivotree Inc
2023
2.48
6.375
CAD
4
ELBM
Electra Battery Materials Corp
2023
2.22
5.9466
CAD
2
CNX
Callinex Mines Inc
2024
2.66
6
CAD
2
GSHR
Goldshore Resources Inc
2024
0.14
5
CAD
1
DMT
Small Pharma Inc
2024
0.07
3.3037
CAD
1
FCA-U
Firm Capital Apartment REIT
2023
3.07
8.2598
CAD
2
GWM
Galway Metals Inc
2023
0.325
3.5
CAD
1
XRTX
XORTX Therapeutics Inc
2023
1.04
11.8932
CAD
1

More about Small Pharma Inc

Small Pharma Inc is a neuropharmaceutical company. It is committed towards the development of effective therapeutic treatments for mental health disorders. Small Pharma is developing N,N-dimethyltryptamine and a pipeline of novel patent-protected deuterium-enriched tryptamine compounds in combination with psychotherapy as potential rapid onset, sustained treatments for depression and other mental health disorders.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

Stock Information

Company Name: Small Pharma Inc.
Stock Symbol: DMT:CC
Market: TSXVC
Website: smallpharma.com

Menu

DMT:CC DMT:CC Quote DMT:CC Short DMT:CC News DMT:CC Articles DMT:CC Message Board
Get DMT:CC Alerts

News, Short Squeeze, Breakout and More Instantly...